Reinforcement of pimobendan with guideline-directed medical therapy may reduce the rehospitalization rates in patients with heart failure: retrospective cohort study

Abstract Background Pimobendan reportedly improves the subjective symptoms of heart failure. However, evidence of improved prognosis is lacking. This study aimed to determine whether reinforcing guideline-directed medical therapy (GDMT) improved rehospitalization rates for worsening heart failure in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yoshiki Iwade, Yoshiaki Kubota, Daisuke Hayashi, Takuya Nishino, Yukihiro Watanabe, Katsuhito Kato, Shuhei Tara, Yuya Ise, Kuniya Asai
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-05-01
Col·lecció:	Journal of Pharmaceutical Health Care and Sciences
Matèries:	Heart failure Pimobendan GDMT
Accés en línia:	https://doi.org/10.1186/s40780-024-00346-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!